483
Lupin LimitedLupin Limited – FDA 483, Mar 2, 2026
Record Details
An FDA inspection of Lupin Limited, an API manufacturer in Ankleshwar, India, revealed significant deficiencies in laboratory operations and production controls. The firm failed to thoroughly investigate numerous analytical incidents and did not follow established procedures for root cause analysis. Additionally, master production and control records lacked clearly defined time limits for processing steps, leading to observed variability.
View Company Profile
ID · de1001f5-29f5-4dfa-ad9e-f3d0150f39d2
Other documents for Lupin Limited
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.